Cannabis Law Report

MAY 16, 2022

per ounce of fresh cannabis plant, and these taxes are paid on all recreational and medicinal cultivation of cannabis. Despite the tax cut, a recent analysis found that removing the cultivation tax would actually increase overall tax revenue from cannabis sales by 123 percent by 2024 due to an expected increase in sales.

Legalization 52

Legalization Collective Education Cultivation 52

Medicinal Genomics

JULY 13, 2023

But Kevin McKernan, our very own CSO and Medicinal Genomics founder, debuted promising new research that found certain cannabis strains exhibit HLVd Viroid resistance, which they signal by turning their leaves purple. The post 12 Things You Missed at CannMed 23 appeared first on Medicinal Genomics. Stay tuned for that.

Research and Development 52

Research and Development Cannabinoids Medicine DEA 52

Medicinal Genomics

JANUARY 10, 2024

CannMed started in 2016, when Medicinal Genomics partnered with Dr. Raphael Mechoulam to host the leading researchers and clinicians in cannabinoid medicine at Boston’s Harvard Medical School. Take a look at the schedule of events , and explore the website to learn more about what makes CannMed the can’t miss cannabis event of 2024!

Research and Development 52

Research and Development Events Education Medicine 52

Veriheal

MAY 19, 2023

The Science Behind Ketamine’s Rise Ketamine has quickly become one of the hottest alternative medicines on the market thanks to its ability to help those with depression and chronic pain. Make sure you check in with a medical professional before pursuing any ketamine treatments. The bill goes into effect on Jan.

Chronic Pain 94

Chronic Pain Data Consumption Safety 94

Cannabis Law Report

NOVEMBER 3, 2021

Khiron in the United Kingdom The company is pursuing a consistent approach to improve patient access to medical cannabis and to develop the market for medical cannabis treatments in the UK. This is a great milestone for Khiron and will contribute significantly to the dynamics of developing a market for medical cannabis in the UK.

Therapy 52

Therapy Access Patients Treatment 52

Cannabis Law Report

JUNE 1, 2021

The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain. billion, servicing nearly 340,000 active patients.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

Veriheal

OCTOBER 1, 2020

African, Asian, American, European, and other countries have all been following the global cannabis movement, whether for recreational or medicinal purposes. The media storm came about as 12-year-old Billy Caldwell and 6-year-old Alfie Dingley were being denied cannabis oil as a treatment for their epilepsy.

Legalization 104

Legalization Oil Medicine Media 104

Cannabis Law Report

JUNE 23, 2021

By 2024, the medicinal cannabis market within the United Kingdom is predicted to be worth nearly US$1.3 has emerged as the largest supplier of medicinal cannabis in the world. In 2019, the island’s economy grew by 2.1% in real terms to £4.97 billion, servicing nearly 340,000 active patients. to reach 3.2

Programs 100

Programs Data Events Collective 100

Cannabis Law Report

MAY 31, 2022

The first path, that of traditional medicine, currently offers patients limited options. Food and Drug Administration (FDA) approved esketamine (a component of Ketamine and sold under the brand name Spravato) for treatment-resistant depression. Commercial Operations. Traditionally Regulated Medical Practice. View source.].

Clinical Trials 52

Clinical Trials Legalization Therapy Decriminalization 52

Cannabis Law Report

NOVEMBER 4, 2021

The Oregon Psilocybin Advisory Board (Advisory Board) held a meeting on October 27 to begin fine tuning recommendations for the first regulated psilocybin treatment model in the United States. These recommendations require OAH to review allowable species every 12 months starting in January 2024. By Brett Mulligan.

Law 52

Law Therapy Treatment Policy 52

Cannabis Law Report

SEPTEMBER 22, 2022

Other bills address employment protection, labelling, use of cannabis in veterinary medicine and taxation. SB 1186– Medicinal Cannabis Patients’ Right of Access Act. AB 1885 – Cannabis & Cannabis Products: Animals: Veterinary Medicine. FOOTNOTES. [1] 1] AB 2188 is discussed in further detail here. Source: [link].

Law 52

Law Events Packaging Pets 52

Cannabis Law Report

DECEMBER 14, 2019

The UK medicinal cannabis market value is forecast to reach almost US$1.3 billion by 2024. Prohibition Partners’ has also estimated that up to 1 per-cent of the UK population could qualify as medical cannabis patients by 2028. Prohibition Partners estimates that there are as many as 3.6 million active cannabis users in the UK.

Pharmaceutical 59

Pharmaceutical Chronic Pain Patients Epilepsy 59

Cannabis Law Report

FEBRUARY 19, 2022

Under current law , the Florida Department of Health (FDOH) is responsible for overseeing the medical cannabis program, including issuing licenses to medical cannabis treatment centers. Advocates now have turned their sights to the 2024 election cycle.

Legalization 97

Legalization Seed-To-Sale Programs Dispensary 97

The Blunt Truth

APRIL 20, 2021

Retail sales will not begin until January 1, 2024. While the law does not provide employment protections to recreational users, New Mexico employers still must be mindful of the protections afforded to those using cannabis for medicinal purposes.

Recreational 77

Recreational Legalization Oil Extraction 77

Cannabis Law Report

DECEMBER 2, 2021

Below is a breakdown of the topics core training covers and the minimum hours students would devote to each subject: Historical, Traditional, and Contemporary Plant Medicine Practices and Applications (12 Hours). Diversity, Cultural and Health Equity, and Racial Justice and Inclusion in relation to Psilocybin Services (12 Hours).

Law 52

Law Programs Therapy Education 52

The Blunt Truth

OCTOBER 24, 2019

The 2019 edition of the Hemp and CBD Industry Factbook released figures that show retail sales of CBD topping $1 billion this year, and predicted that number could hit $10 billion by 2024. Tourette syndrome and intractable neuropathic pain are now eligible for treatment with medical cannabis.

Hemp 58

Hemp DEA CBD Topical 58

The Blunt Truth

JANUARY 5, 2022

Retail sales will not begin until January 1, 2024. Thus, employers should consider having in place a clear policy and procedure for addressing accommodation requests from applicants and employees using medicinally. Virginia addressed both recreational marijuana and cannabis oil. There are a handful of narrow exceptions.

Law 105

Law Marijuana Policy Recreational 105

The Joint Blog

JANUARY 8, 2020

The medicines are touted as being based on traditional remedies. billion by 2024. At least it can lessen the side effects of the modern chemical-based medicines that they’ve been taking for 10 or 20 years,” he said, referring to chemotherapy for cancer patients. Officials say the policy of free cannabis is likely to be changed.

Marijuana 26

Marijuana Oil Patients Medicine 26

The Joint Blog

AUGUST 1, 2019

According to an article published on Forbes, the CBD market is only growing and is expected to hit $20 billion by 2024. With many people sadly being diagnosed with cancer today, CBD could be the biggest hope that cancer patients have to help relieve symptoms of cancer treatments. What is CBD? Is the CBD craze worth it?

CBD 37

CBD Wellness and Beauty Vaping Oil 37

The Cannigma

FEBRUARY 21, 2021

billion by 2024. Some of the largest companies in cannabis, like Tilray , invest heavily in research and development of medical cannabis products and treatments. Or in other words, doing things that make your life and physical and mental health better beyond the confines of traditional medicine. The power of federal reform.

Research and Development 118

Research and Development Pharmaceutical Recreational Cannabis 118

Cannabis Law Report

JANUARY 3, 2022

Retail sales will not begin until January 1, 2024. Thus, employers should consider having in place a clear policy and procedure for addressing accommodation requests from applicants and employees using medicinally. Virginia addressed both recreational marijuana and cannabis oil. There are a handful of narrow exceptions.

Law 52

Law Marijuana Policy Recreational 52

Cannabis Law Report

AUGUST 18, 2021

The retail sale of marijuana in Virginia, however, will not begin until January 1, 2024. The Hall Act expressly does not allow for the use of cannabis products that are smoked or vaped, baked goods, or candies. Virginia’s recreational marijuana law does not address any obligations or protections in the employment context. View source.].

Legislation 105

Legislation Legalization Marijuana Recreational 105

Veriheal

JUNE 9, 2023

Florida Sets Stage for 2024 Cannabis Face-off A cannabis legalization initiative backed by cannabis company Trulieve is making its way to Florida’s 2024 ballot! Psilocybin-based Medicine Under Development Massachusetts-based biotech company Enteric Biosciences is looking to become a leader in psilocybin medicine.

Legalization 93

Legalization Retail Medicine Concentrates 93

The Blunt Truth

DECEMBER 9, 2022

President Biden signed an act allowing researchers to study cannabis, in an effort to learn more about its medicinal properties. Our new law will remove excessive barriers that make it difficult for researchers to study the effectiveness and safety of marijuana, and hopefully, give patients more treatment options.” MARIJUANA RESEARCH.

Banking 110

Banking Collective Safety Treatment 110

Cannabis Law Report

AUGUST 10, 2021

Spravato is the first “psychedelic-like” medicine approved for a mental health indication in both the U.S. Ketamine and its treatment protocols are effectively laying the groundwork for the development of an infrastructure that could ultimately result in the introduction of psychedelics in a clinical setting. and Canada. What Happened?

Data 98

Data Pharmaceutical Treatment Medicine 98

Cannabis Law Report

JULY 8, 2021

Despite the fact that cannabis also isn’t approved for use by the Food & Drug Administration, advocacy organizations claim that smoking cannabis is a viable treatment for a number of behavioral and health issues, ranging from tension and worry to Frontotemporal disease and Parkinson’s disease (FDA). billion by 2024.

Legalization 98

Legalization Advocacy Legislation Cannabis 98

Cannabis Law Report

AUGUST 19, 2021

Traditional medicine practitioners are an additional and particularly influential group of stakeholders, unique to Thailand, as they utilize longstanding traditional formulations containing cannabis. The Narcotics Act amendment (No. 7) came into effect, legalizing medical use of substances listed as category 5 narcotics (e.g.,

Hemp 105

Hemp Business Research and Development Sativa 105

Cannabis Law Report

AUGUST 30, 2019

Americans for Safe Access released its 2018-2019 State-of-the-State report examining state laws and regulations surrounding Patient Rights and Civil Protection from Discrimination, Access to Medicine, Ease of Navigation, Functionality of the Programs, and Consumer Safety and Provider Requirements. billion by 2024.

Banking 45

Banking Research and Development Legislation Programs 45

SpeedWeed

MARCH 15, 2021

By casting marijuana as “essential,” states put the cannabis industry in the same category as pharmacies, hospitals and other sources of legitimate medicine. In short, cannabis went from an alternative treatment to an essential medicine, giving it a major upgrade in credibility. 1, 2024, start.

Marijuana 52

Marijuana Banking Recreational Programs 52

Canna Law Blog

MARCH 7, 2023

Similarly, in spite of dozens of states enacting legislation that allows for recreational or medicinal use of cannabis, it remains federally illegal to possess, produce, and sell under the Controlled Substances Act (“CSA”) as a schedule I substance. The INA is federal law and administered by the U.S. government changes course in 2025.

DEA 69

DEA Research and Development Programs Cannabis 69

Veriheal

SEPTEMBER 22, 2021

The latest rule adoption demonstrates growing acceptance for the plant in its medicinal form. . A lack of legal medical cannabis in North Carolina means that patients who rely on plant-based treatment are forced to either go without or seek out the plant from alternative sources, such as the unregulated black market.

Legalization 111

Legalization Patients Cultivation Legislation 111

Kind Meds (Cannabis Education Blog)

FEBRUARY 7, 2022

Our ancestors consumed cannabis flower for recreational, medicinal, and spiritual purposes. This scheduling is clearly at odds with public opinion, as 91% of Americans believe that cannabis should be legal either for medicinal or recreational use.

Recreational 52

Recreational Data Cannabis DEA 52

Cannabis Law Report

JUNE 30, 2019

The House also included amendments transferring $5 million from the Drug Enforcement Administration to opioid treatment programs, and directing the Food and Drug Administration to establish regulations for adding CBD to food and dietary supplements. billion in 2024, nearly triple the US$14.9 Illinois J.B. Molson Coors Brewing Co.

Chronic Pain 40

Chronic Pain Legislation Treatment Programs 40

Cannabis Law Report

NOVEMBER 29, 2021

The retail provisions are set to take effect on January 1, 2024, but this deadline could be expedited by lawmakers. Senate Bill 311 : This legislation provides for “a terminally ill patient’s use of medicinal cannabis within [a] health care facility.” The personal use provisions took effect on July 1, 2021. DECRIMINALIZATION.

Legislation 98

Legislation Patients Retail Access 98